Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzalkonium chloride + ethanol is a synergistic topical antiseptic combination used primarily for hand hygiene and skin disinfection. Ethanol, typically present in concentrations between 60% and 80%, acts rapidly to kill a broad spectrum of bacteria, viruses, and fungi by denaturing essential proteins and dissolving lipid membranes. Benzalkonium chloride, a quaternary ammonium compound, complements this by providing persistent antimicrobial activity after the alcohol has evaporated. It works by adsorbing to and disrupting the cytoplasmic membrane of microorganisms, leading to leakage of cellular contents. This combination is widely utilized in healthcare settings to reduce the risk of healthcare-associated infections and in consumer products for general sanitization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzalkonium chloride + ethanol.